Boston Health Economics (BHE) is a full-service outcomes research organization specializing in the economic evaluation of pharmaceuticals, medical devices, and disease management programs. BHE delivers high-quality, objective consulting services to inform strategy and enhance value.
Founded in 1996, BHE is an independent, full-service outcomes research organization. Our core services center around economic evaluation of medical technologies at all phases of development. We offer the advantage of creative, multidisciplinary research teams as well as unique access to diverse data sources. BHE researchers have expertise in fields such as health economics, medicine, epidemiology, information technology, policy analysis, and statistics. With immediate access to BHE's sizeable data warehouse, we can perform timely and precise population-based studies in a wide range of therapeutic areas. BHE frequently collaborates with expert academic investigators, clinical research centers, and managed care organizations (MCOs) in the U.S. and abroad.
Our mission is to provide our clients with creative, high-quality work backed by conscientious customer service. BHE's high standards have produced numerous publications in the peer-reviewed literature and long-lasting client relationships. We work with leading pharmaceutical companies, medical device manufacturers, government agencies, and academic institutions. Our clients know they will receive high-quality outcomes support and data worthy of widespread use and dissemination.